Ian Frank

18.1k total citations · 2 hit papers
157 papers, 9.5k citations indexed

About

Ian Frank is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ian Frank has authored 157 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 70 papers in Virology and 59 papers in Epidemiology. Recurrent topics in Ian Frank's work include HIV Research and Treatment (68 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (46 papers). Ian Frank is often cited by papers focused on HIV Research and Treatment (68 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (46 papers). Ian Frank collaborates with scholars based in United States, United Kingdom and Botswana. Ian Frank's co-authors include Ronald G. Collman, Harvey M. Friedman, Pablo Tebas, Kyle Bittinger, Andrew R. Haas, Frederic D. Bushman, Emily S. Charlson, Ayannah S. Fitzgerald, Anjana Yadav and Giorgio Trinchieri and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Ian Frank

156 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

2014 973 citations Pablo Tebas, Ian Frank et al. profile →
Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract

2011 814 citations Ian Frank, Ronald G. Collman et al. profile →

Peers

Countries citing papers authored by Ian Frank

Since Specialization

Citations

This map shows the geographic impact of Ian Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Frank more than expected).

Fields of papers citing papers by Ian Frank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Frank. The network helps show where Ian Frank may publish in the future.

Co-authorship network of co-authors of Ian Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Frank. A scholar is included among the top collaborators of Ian Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Frank. Ian Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy 2022 ·Cell Reports Medicine ·Jonathan D. Herman, Chuangqi Wang, John S. Burke, (unknown), (unknown), Jaewon Kang, (unknown), (unknown), Sally Shin, Ian Frank, Don L. Siegel, Pablo Tebas, Grace Choi, Pamela A. Shaw, Hyunah Yoon, Liise-anne Pirofski, Boris Jülg, Katharine J. Bar, Douglas A. Lauffenburger, Galit Alter	17
2	Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial 2021 ·AIDS Patient Care and STDs ·John B. Jemmott, Loretta Sweet Jemmott, Jingwen Zhang, Larry D. Icard, (unknown), Ian Frank, Scarlett L. Bellamy	5
3	Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1 2020 ·Proceedings of the National Academy of Sciences ·Lynn N. Bertagnolli, Joseph Varriale, (unknown), (unknown), Francesco R. Simonetti, Jennifer A. White, Subul Beg, Kenneth Lynn, Karam Mounzer, Ian Frank, Pablo Tebas, Katharine J. Bar, Luis J. Montaner, Robert F. Siliciano, Janet D. Siliciano	46
4	Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV 2019 ·Drug and Alcohol Dependence ·Rebecca L. Ashare, (unknown), Katrina J. Serrano, Frank T. Leone, David S. Metzger, Ian Frank, Robert Gross, Anita Hole, Karam Mounzer, Ronald G. Collman, E. Paul Wileyto, Robert A. Schnoll	35
5	Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial 2018 ·HIV Clinical Trials ·Miranda Murray, Martin Markowitz, Ian Frank, Robert M. Grant, Kenneth H. Mayer, Krischan J Hudson, Britt Stancil, Susan L. Ford, Parul Patel, Alex R. Rinehart, William Spreen, David A. Margolis	54
6	Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants 2017 ·AIDS and Behavior ·Kathrine Meyers, Kristina Rodriguez, (unknown), Yumeng Wu, (unknown), (unknown), Beryl A. Koblin, David M. Margolis, Magdalena E. Sobieszczyk, Hong‐Van Tieu, Ian Frank, Martin Markowitz, Sarit A. Golub	26
7	Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial 2017 ·The Lancet HIV ·Martin Markowitz, Ian Frank, Robert M. Grant, Kenneth H. Mayer, Richard Elion, Deborah Goldstein, (unknown), Magdalena E. Sobieszczyk, Joel E. Gallant, Hong‐Van Tieu, Winkler G. Weinberg, David A. Margolis, Krischan J Hudson, Britt Stancil, Susan L. Ford, Parul Patel, Elizabeth Gould, Alex R. Rinehart, Kimberly Y. Smith, William Spreen	164
8	For a fistful of dollars: using crowd-sourcing to evaluate a spoken language CALL application 2011 ·Archive ouverte UNIGE (University of Geneva) ·Manny Rayner, Ian Frank, (unknown), (unknown), Pierrette Bouillon	12
9	CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection 2008 ·The Journal of Immunology ·Richard M. Dunham, Barbara Cervasi, Jason M. Brenchley, Helmut Albrecht, Amy Weintrob, Beth Sumpter, Jessica C. Engram, Shari N. Gordon, Nichole R. Klatt, Ian Frank, Donald L. Sodora, Daniel C. Douek, Mirko Paiardini, Guido Silvestri	97
10	Effect of Hydroxyurea and Dideoxyinosine on Intracellular 3′-Deoxyadenosine-5′-triphosphate Concentrations in HIV-Infected Patients 2007 ·AIDS Research and Human Retroviruses ·Rahul P. Bakshi, Fayez M. Hamzeh, Ian Frank, Joseph J. Eron, Ronald J. Bosch, Susan L. Rosenkranz, Yoninah Cramer, Michael A. Ussery, Charles Flexner	4
11	Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection 2006 ·The Journal of Immunology ·Helen Horton, Ian Frank, Ruth Baydo, Emilie Jalbert, Justin L. Penn, Sean Wilson, John McNevin, (unknown), Deborah Lee, Yunda Huang, Stephen C. De Rosa, M. Juliana McElrath	91
12	Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency 2005 ·AIDS Research and Human Retroviruses ·Franco Lori, Richard B. Pollard, Lucia Whitman, Nyasha Bakare, Gary Blick, (unknown), Andrea Foli, D. M. Peterson, Alan M. Tennenberg, Shannon Schrader, Bruce Rashbaum, Charles Farthing, (unknown), D. B. Norris, (unknown), Ian Frank, (unknown), (unknown), David M. Asmuth, Julianna Lisziewicz	9
13	HIV Type 1 Cervicovaginal Reservoirs in the Era of HAART 2005 ·AIDS Research and Human Retroviruses ·Giuseppe Nunnari, Julie Sullivan, Yan Xu, Paul Nyirjesy, Joseph Kulkosky, Winston Cavert, Ian Frank, Roger J. Pomerantz	25
14	Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248) 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler, Hedy Teppler, Rebecca Gelman, Fred Valentine, Michael M. Lederman, Roger J. Pomerantz, Richard B. Pollard, (unknown), Charles J. Gonzalez, Kathleen Squires, Ian Frank, Donna Mildvan, (unknown), Barbara Schock	15
15	Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART 2003 ·AIDS Research and Human Retroviruses ·Miguel Otero, Giuseppe Nunnari, (unknown), Julie Sullivan, Fengxiang Wang, Ian Frank, Yan Xu, Charvi Patel, Geethanjali Dornadula, Joseph Kulkosky, Roger J. Pomerantz	45
16	Efavirenz Is a Potent Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1 Replication in Microglia in Vitro 2000 ·AIDS Research and Human Retroviruses ·Andrew Albright, Susan Erickson‐Viitanen, Michael J. O’Connor, Ian Frank, Marlene M. Rayner, Francisco González‐Scarano	11
17	Pulmonary Aspergillosis in Patients With AIDS 1994 ·CHEST Journal ·Wallace T. Miller, (unknown), Ian Frank, Warren B. Gefter, Judith M. Aronchick	100
18	Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. 1994 ·American Journal of Neuroradiology ·(unknown), Jeffrey G. Jarvik, Robert E. Lenkinski, Robert I. Grossman, Ian Frank, Maria Delivoria‐Papadopoulos	18
19	Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. 1992 ·Journal of Clinical Investigation ·Kenneth E. Ugen, James J. Goedert, Jean Boyer, Yosef Refaeli, Ian Frank, William V. Williams, (unknown), Sheldon H. Landesman, (unknown), A. Rubinstein	70
20	10th European Conference on Artificial Intelligence, ECAI 92, Vienna, Austria, August 3-7, 1992. Proceedings. 1992 ·European Conference on Artificial Intelligence ·Ian Frank, David Basin, Alan Bundy	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact